Consider Ezetimibe as a Statin Add-On

July 2015

You'll continue to see LESS use of non-statins (niacin, etc) for dyslipidemia...due to limited evidence of CV benefit.

Consider discontinuing non-statins when patients are admitted if there's no good reason for the patient to be on them.

Use these tips to evaluate the need for non-statins.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Learn More

Already a subscriber? Log in

Not sold to individuals

Table of Contents

Medical Errors Help Develop Protocols to Reduce "Never Events"
Pulmonary Embolism Expect Less Use of IVC Filters With Anticoagulation
Dyslipidemia Consider Ezetimibe as a Statin Add-On
Antipsychotics Don't Treat Insomnia With Antipsychotics
Controlled Substances Recommend Naloxone at Discharge for Patients at Risk of Opioid Overdose
Med Safety Stop Gliptins in Patients Admitted With Heart Failure
Med Safety Treat Flozin Ketoacidosis With Your Diabetic Ketoacidosis Protocol
Probiotics Schedule a Probiotic At Least 2 Hours After an Antibiotic
New Drugs Watch for Duplicate Carbidopa/Levodopa Orders on Discharge Paperwork
Opioids Verify Fentanyl Patch Dose on Admission
Hepatitis C Don't Rely on Pentoxifylline for Alcoholic Hepatitis